These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24279288)

  • 1. Heparin promotes the rapid fibrillization of a peptide with low intrinsic amyloidogenicity.
    Madine J; Davies HA; Hughes E; Middleton DA
    Biochemistry; 2013 Dec; 52(50):8984-92. PubMed ID: 24279288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension.
    Solomon JP; Bourgault S; Powers ET; Kelly JW
    Biochemistry; 2011 Apr; 50(13):2486-98. PubMed ID: 21348501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of amyloid formation by glucagon-like peptides: role of basic residues in heparin-mediated aggregation.
    Jha NN; Anoop A; Ranganathan S; Mohite GM; Padinhateeri R; Maji SK
    Biochemistry; 2013 Dec; 52(49):8800-10. PubMed ID: 24236650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.
    Vilasi S; Sarcina R; Maritato R; De Simone A; Irace G; Sirangelo I
    PLoS One; 2011; 6(7):e22076. PubMed ID: 21779376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
    Ohnishi S; Koide A; Koide S
    J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents.
    Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA
    Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant.
    Bazar E; Jelinek R
    Chembiochem; 2010 Sep; 11(14):1997-2002. PubMed ID: 20799315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of kinetic pathways in amyloid fibril formation.
    Bellesia G; Shea JE
    J Chem Phys; 2009 Sep; 131(11):111102. PubMed ID: 19778093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
    Ariga T; Miyatake T; Yu RK
    J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I.
    Mikawa S; Mizuguchi C; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Sakashita N; Otaka A; Akaji K; Saito H
    FEBS Lett; 2016 Oct; 590(20):3492-3500. PubMed ID: 27654470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin assisted assembly of somatostatin amyloid nanofibrils results in disordered precipitates by hindrance of protofilaments interactions.
    Dharmadana D; Reynolds NP; Dekiwadia C; Conn CE; Valéry C
    Nanoscale; 2018 Oct; 10(38):18195-18204. PubMed ID: 30141801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
    Castillo GM; Lukito W; Wight TN; Snow AD
    J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting a (13)C-labelled heparin analogue for in situ solid-state NMR investigations of peptide-glycan interactions within amyloid fibrils.
    Madine J; Clayton JC; Yates EA; Middleton DA
    Org Biomol Chem; 2009 Jun; 7(11):2414-20. PubMed ID: 19462052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro.
    Yamaguchi I; Suda H; Tsuzuike N; Seto K; Seki M; Yamaguchi Y; Hasegawa K; Takahashi N; Yamamoto S; Gejyo F; Naiki H
    Kidney Int; 2003 Sep; 64(3):1080-8. PubMed ID: 12911560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans.
    Brunden KR; Richter-Cook NJ; Chaturvedi N; Frederickson RC
    J Neurochem; 1993 Dec; 61(6):2147-54. PubMed ID: 8245966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.
    Wall JS; Martin EB; Richey T; Stuckey AC; Macy S; Wooliver C; Williams A; Foster JS; McWilliams-Koeppen P; Uberbacher E; Cheng X; Kennel SJ
    Molecules; 2015 Apr; 20(5):7657-82. PubMed ID: 25923515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.